• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Canada's Recreational Cannabis Legalization and Medical Cannabis Patient Activity, 2017-2022.加拿大休闲大麻合法化与医疗大麻患者活动:2017-2022 年
Am J Public Health. 2024 Nov;114(S8):S673-S680. doi: 10.2105/AJPH.2024.307721. Epub 2024 Oct 3.
2
Changes in Medical Cannabis Use After Recreational Cannabis Legalization in Canada.加拿大娱乐用大麻合法化后医用大麻使用的变化。
Cannabis Cannabinoid Res. 2024 Feb;9(1):335-342. doi: 10.1089/can.2022.0227. Epub 2023 Jan 31.
3
Pediatric Hospitalizations for Unintentional Cannabis Poisonings and All-Cause Poisonings Associated With Edible Cannabis Product Legalization and Sales in Canada.加拿大食用大麻合法化和销售后与意外大麻中毒和所有原因中毒相关的儿科住院治疗。
JAMA Health Forum. 2023 Jan 6;4(1):e225041. doi: 10.1001/jamahealthforum.2022.5041.
4
Association between non-medical cannabis legalization and alcohol sales: Quasi-experimental evidence from Canada.非医用大麻合法化与酒类销售的关联:来自加拿大的准实验证据。
Drug Alcohol Depend. 2024 Apr 1;257:111137. doi: 10.1016/j.drugalcdep.2024.111137. Epub 2024 Feb 27.
5
The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis.加拿大安大略省娱乐用大麻合法化、商业化与因大麻就诊的急诊科人次之间的关联:一项中断时间序列分析
Addiction. 2022 Jul;117(7):1952-1960. doi: 10.1111/add.15834. Epub 2022 Feb 17.
6
Legal cannabis market shares during Canada's first year of recreational legalisation.加拿大娱乐用大麻合法化首年的合法大麻市场份额。
Int J Drug Policy. 2021 Feb;88:103028. doi: 10.1016/j.drugpo.2020.103028. Epub 2020 Nov 19.
7
Relationships between sales of legal medical cannabis and alcohol in Canada.加拿大合法医用大麻与酒精的销售关系。
Health Policy. 2023 Feb;128:28-33. doi: 10.1016/j.healthpol.2022.11.012. Epub 2022 Nov 23.
8
Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic.加利福尼亚州娱乐用大麻合法化和 COVID-19 大流行后大麻暴露情况的变化。
Clin Toxicol (Phila). 2022 May;60(5):632-638. doi: 10.1080/15563650.2021.2006212. Epub 2021 Dec 6.
9
Out-of-state cannabis purchases in the United States.美国的州外大麻购买。
Drug Alcohol Depend. 2020 Feb 1;207:107822. doi: 10.1016/j.drugalcdep.2019.107822. Epub 2019 Dec 23.
10
The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.娱乐用大麻获取途径合法化对加拿大癌症医用患者的影响。
BMC Health Serv Res. 2020 Oct 27;20(1):977. doi: 10.1186/s12913-020-05756-8.

引用本文的文献

1
Understanding medical cannabis use internationally: Why definitions and context matter.国际上对医用大麻使用的理解:为何定义和背景至关重要。
Addiction. 2025 Oct;120(10):2141-2146. doi: 10.1111/add.70117. Epub 2025 Jul 1.
2
Cannabis: Zone Aspects of Raw Plant Components in Sport-A Narrative Review.大麻:体育赛事中未加工植物成分的区域相关情况——一篇叙述性综述
Nutrients. 2025 Feb 28;17(5):861. doi: 10.3390/nu17050861.

本文引用的文献

1
How to interpret studies on the impact of legalizing cannabis.如何解读关于大麻合法化影响的研究。
Addiction. 2023 Nov;118(11):2242-2243. doi: 10.1111/add.16314. Epub 2023 Aug 6.
2
Medical Cannabis Program Sustainability in the Era of Recreational Cannabis.医用大麻项目在娱乐大麻时代的可持续性。
Clin Ther. 2023 Jun;45(6):578-588. doi: 10.1016/j.clinthera.2023.01.017.
3
Why a distinct medical stream is necessary to support patients using cannabis for medical purposes.为什么需要一个独特的医学分支来支持将大麻用于医疗目的的患者。
J Cannabis Res. 2023 Jul 4;5(1):25. doi: 10.1186/s42238-023-00195-8.
4
The effects of the 4/20 cannabis holiday and adult-use cannabis legalization on medical cannabis sales and medical cannabis patient registration in Arizona.4月20日大麻节及成人用大麻合法化对亚利桑那州医用大麻销售和医用大麻患者注册的影响。
Int J Drug Policy. 2023 Apr;114:103974. doi: 10.1016/j.drugpo.2023.103974. Epub 2023 Feb 26.
5
The role of cannabis clinics in the health system: a qualitative study of physicians' views in New Zealand.大麻诊所在卫生系统中的作用:新西兰医生观点的定性研究。
BMC Health Serv Res. 2023 Jan 4;23(1):10. doi: 10.1186/s12913-022-09021-y.
6
Relationships between sales of legal medical cannabis and alcohol in Canada.加拿大合法医用大麻与酒精的销售关系。
Health Policy. 2023 Feb;128:28-33. doi: 10.1016/j.healthpol.2022.11.012. Epub 2022 Nov 23.
7
Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices.医疗保健从业者对影响大麻处方实践障碍的看法。
BMC Complement Med Ther. 2022 Sep 8;22(1):237. doi: 10.1186/s12906-022-03716-9.
8
Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20).澳大利亚的医用大麻使用情况:来自 2020 年在线医用大麻调查(CAMS-20)的消费者体验。
Harm Reduct J. 2022 Jul 30;19(1):88. doi: 10.1186/s12954-022-00666-w.
9
U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020 : An Observational Study.2016 年至 2020 年美国医用大麻登记趋势及使用原因:一项观察性研究。
Ann Intern Med. 2022 Jul;175(7):945-951. doi: 10.7326/M22-0217. Epub 2022 Jun 14.
10
Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020.美国休闲大麻法律是否与医疗大麻项目注册人数下降有关?对 2013 年至 2020 年持卡人注册和人口统计特征的分析。
Int J Drug Policy. 2022 Feb;100:103531. doi: 10.1016/j.drugpo.2021.103531. Epub 2021 Nov 21.

加拿大休闲大麻合法化与医疗大麻患者活动:2017-2022 年

Canada's Recreational Cannabis Legalization and Medical Cannabis Patient Activity, 2017-2022.

机构信息

Michael J. Armstrong is an associate professor of operations research, Brock University, St. Catharines, ON, Canada.

出版信息

Am J Public Health. 2024 Nov;114(S8):S673-S680. doi: 10.2105/AJPH.2024.307721. Epub 2024 Oct 3.

DOI:10.2105/AJPH.2024.307721
PMID:39361903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11499694/
Abstract

To estimate changes in medical cannabis patient activity after Canada's recreational cannabis legalization. I used linear regressions of interrupted times series models to analyze medical cannabis patient registrations per 10 000 residents, purchases per 100 registrations, and packages per purchase in Canada's 10 provinces between April 2017 and December 2022. I tested relationships between the recreational law's passage in June 2018, recreational sales starting in October 2018, and the arrival of edibles and vapes in December 2019. Medical patient registrations initially increased; they slowed after the law passed and started decreasing after edibles became available. Medical purchasing frequencies initially decreased; they decreased further in proportion to recreational sales but stabilized after edibles became available. Medical purchase sizes were initially stable; they began increasing after edibles became available. Canada saw substantial decreases in medical cannabis patient registrations, but the remaining patients stabilized their purchasing frequencies and increased their purchase sizes. Other countries might see significant changes in patient usage of their medical cannabis systems after nationwide recreational cannabis legalization. (. 2024;114(S8):S673-S680. https://doi.org/10.2105/AJPH.2024.307721).

摘要

评估加拿大休闲大麻合法化后医用大麻患者活动的变化。我使用中断时间序列模型的线性回归分析了 2017 年 4 月至 2022 年 12 月加拿大 10 个省每 10000 名居民的医用大麻患者登记人数、每 100 名登记患者的购买量和每次购买的包装数量。我测试了 2018 年 6 月休闲法律通过、2018 年 10 月开始休闲销售以及 2019 年 12 月可食用和蒸气产品到达之间的关系。医用患者登记人数最初增加;在法律通过后,登记人数增长放缓,在可食用产品上市后开始减少。医用购买频率最初下降;它们与休闲销售的比例进一步下降,但在可食用产品上市后稳定下来。医用购买规模最初保持稳定;在可食用产品上市后开始增加。加拿大医用大麻患者登记人数大幅减少,但剩余患者稳定了购买频率并增加了购买量。其他国家在全国范围内休闲大麻合法化后,可能会看到患者对其医用大麻系统的使用发生重大变化。(2024 年;114(S8):S673-S680。https://doi.org/10.2105/AJPH.2024.307721)。